A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction

NCT00203476 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Hyperlipidemia
Hypercholesterolemia

Interventions

DRUG: Niacin
DRUG: Colestipol
DRUG: Ezetimibe

Sponsor

Tuscaloosa Research & Education Advancement Corporation

Collaborators

[object Object]